![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Homepage | Open Heart
Open Heart. is an open access journal by BMJ and BCS, publishing original research in cardiovascular medicine. Impact Factor: 2.8 Citescore: 4.6 All metrics >>
Four pillars of heart failure: contemporary ... - Open Heart
Mar 2, 2021 · The past two decades have heralded dramatic improvements in outcomes for people living with heart failure with reduced ejection fraction (HFrEF). 1 The more widespread implementation of disease modifying pharmacological therapies,2 supported by landmark trials of renin-angiotensin system inhibitors3 and beta-blockers4 have improved longevity despite a background of an ageing and increasingly ...
Homepage | Open Heart
An open access cardiology journal publishing original research and opinion on cardiovascular medicine at all study phases.
Transcatheter mitral valve repair: an overview of current and future ...
Apr 27, 2021 · The field of transcatheter mitral valve repair (TMVr) for mitral regurgitation (MR) is rapidly evolving. Besides the well-established transcatheter mitral edge-to-edge repair approach, there is also growing evidence for therapeutic strategies targeting the mitral annulus and mitral valve chordae. A patient-tailored approach, careful patient selection and an experienced interventional team is ...
Epidemiology of myocarditis following COVID-19 or influenza and …
Nov 9, 2024 · Introduction. Myocarditis is an inflammatory process of the myocardium, and the most common cause is a viral infection such as influenza or coronaviruses.1 While most cases of viral myocarditis are mild with good prognosis, life-threatening cardiac dysfunction and arrhythmias may occur.2 3 Myocarditis can result in heart failure and sudden cardiac death and has been recognised as a rare ...
Myocarditis after COVID-19 and influenza infections: insights from …
Nov 13, 2024 · In the current issue of Open Heart, the study by Butler and colleagues completed a much-needed investigation that provides valuable insights into the risk of developing incident myocarditis in the general population following COVID-19 or influenza infection. The authors used a large, USA-based administrative health claims database to complete a retrospective analysis of the risk of myocarditis ...
Ivermectin may be a clinically useful anti-inflammatory agent for …
Sep 5, 2020 · Ivermectin, on the WHO’s List of Essential Medications, has been in clinical use since 1981 as an orally and topically active agent for treating a range of parasitic infections in humans, including river blindness and lymphatic filariasis. It …
Acute myocarditis caused by COVID-19 disease and following …
Mar 8, 2022 · COVID-19 postvaccination myocarditis. To end the COVID-19 pandemic, vaccination is an essential component of the public health strategy. Large, randomised controlled trials of COVID-19 vaccines were found safe and effective in preventing laboratory-confirmed symptomatic COVID-1924–26; even though, adverse effects have been reported.In the specific group population of young adults and ...
Topic Collections - Open Heart
Edited by Anastasia Shchendrygina, Clara Ines Saldarriaga Revolutionary improvements in heart failure (HF) treatment have been made in recent years, including the introduction of novel therapies like SGLT-2 inhibitors for HF with preserved ejection fraction (HFpEF). However, further research is needed on implementing these therapies worldwide, addressing challenges in …
Mixed plaque on coronary CT angiography predicts …
Mar 8, 2024 · Objective Coronary CT angiography (CCTA) permits both qualitative and quantitative analysis of atherosclerotic plaque and may be a suitable risk modifier in assessing patients at intermediate risk of atherosclerotic cardiovascular disease. We sought to determine the association of plaque components with long-term major adverse cardiovascular events (MACEs) in asymptomatic intermediate-risk ...